UPDATE: Baird Downgrades Quest Diagnostics (DGX) to Neutral
Tweet Send to a Friend
(Updated - March 12, 2021 7:30 AM EST)
Baird analyst Eric Coldwell downgraded Quest Diagnostics (NYSE: DGX) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Eric Coldwell downgraded Quest Diagnostics (NYSE: DGX) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
